ArticlePloS one2021

Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?

Josep Lupón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.